Drug-induced gingival overgrowth and class II major histocompatibility antigens.
Pernu
H E
HE
Institute of Dentistry, University of Oulu, Finland.
Knuuttila
M L
ML
Huttunen
K R
KR
Tiilikainen
A S
AS
D000328:Adult; D017311:Amlodipine / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology; D015736:Felodipine / Q000009:adverse effects*; D005260:Female; D005881:Gingiva / Q000187:drug effects* / Q000473:pathology; D005882:Gingival Diseases / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D006684:HLA-DR Antigens; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D009543:Nifedipine / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors
D006684:HLA-DR Antigens; D017311:Amlodipine; D016572:Cyclosporine; D009543:Nifedipine; D001379:Azathioprine; D015736:Felodipine